Large-scale testing (Phase 3)Study completedNCT00334880
What this trial is testing
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Who this might be right for
Attention Deficit Hyperactivity DisorderAttention Deficit Disorders With HyperactivityAttention Deficit Hyperactivity Disorders
New River Pharmaceuticals 420